João Marcelo Pereira Alves

Dr. João Marcelo Pereira Alves

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2004 in Nature
Verified
Journal Article
Open access
PXPing Xu
Ping Xu
GWGiovanni Widmer
Giovanni Widmer
YWYingping Wang
Yingping Wang
LOLuiz S. Ozaki
Luiz S. Ozaki
JAJoão Marcelo Pereira Alves
João Marcelo Pereira Alves
GBGregory A. Buck
Gregory A. Buck
Nature is the international weekly journal of science: a magazine style journal that publishes full-length research papers in all disciplines of science, as well as News and Views, reviews, news, features, commentaries, web focuses and more, covering all branches of science and how science impacts upon all aspects of society and life.

28 September 2013 in Gut Microbes
Verified
Journal Article
Open access
JRJason M Ridlon
Jason M Ridlon
JAJoão Marcelo Pereira Alves
João Marcelo Pereira Alves
PHPhillip B Hylemon
Phillip B Hylemon
JBJasmohan Bajaj
Jasmohan Bajaj
A picture is now starting to emerge regarding the liver-bile acid-microbiome axis. Increasing levels of the primary bile acid cholic acid (CA) causes a dramatic shift toward the Firmicutes, particularly Clostridium cluster XIVa and increasing production of the harmful secondary bile acid deoxycholic acid (DCA). During progression of cirrhosis, the microbiome, both through their metabolism, cell wall components (LPS) and translocation lead to inflammation. Inflammation suppresses synthesis of bile acids in the liver leading to a positive-feedback mechanism. Decrease in bile acids entering the intestines appears to favor overgrowth of pathogenic and pro-inflammatory members of the microbiome including Porphyromonadaceae and Enterobacteriaceae. Decreasing bile acid concentration in the colon in cirrhosis is also associated with decreases in Clostridium cluster XIVa, which includes bile acid 7α-dehydroxylating bacteria which produce DCA. Rifaximin treatment appears to act by suppressing DCA production, reduci...

1 September 2013 in Journal of Lipid Research
Verified
Journal Article
Open access
PDF file
JRJason M. Ridlon
Jason M. Ridlon
SIShigeo Ikegawa
Shigeo Ikegawa
JAJoão Marcelo Pereira Alves
João Marcelo Pereira Alves
BZBiao Zhou
Biao Zhou
AKAkiko Kobayashi
Akiko Kobayashi
PHPhillip B. Hylemon
Phillip B. Hylemon
Jason M. Ridlon, Shigeo Ikegawa, João M. P. Alves, Biao Zhou, Akiko Kobayashi, Takashi Iida, Kuniko Mitamura, Genzoh Tanabe, Myrna Serrano, Ainee De Guzman, Patsy Cooper, Gregory A. Buck, Phillip B. Hylemon

15 April 2007 in Journal of Bacteriology
Verified
Journal Article
Open access
PDF file
PXPing Xu
Ping Xu
JAJoão Marcelo Pereira Alves
João Marcelo Pereira Alves
TKTodd Kitten
Todd Kitten
ABArunsri Brown
Arunsri Brown
ZCZhenming Chen
Zhenming Chen
GBGregory Buck
Gregory Buck
The genome of Streptococcus sanguinis is a circular DNA molecule consisting of 2,388,435 bp and is 177 to 590 kb larger than the other 21 streptococcal genomes that have been sequenced. The G+C content of the S. sanguinis genome is 43.4%, which is considerably higher than the G+C contents of other streptococci. The genome encodes 2,274 predicted proteins, 61 tRNAs, and four rRNA operons. A 70-kb region encoding pathways for vitamin B 12 biosynthesis and degradation of ethanolamine and propanediol was apparently acquired by horizontal gene transfer. The gene complement suggests new hypotheses for the pathogenesis and virulence of S. sanguinis and differs from the gene complements of other pathogenic and nonpathogenic streptococci. In particular, S. sanguinis possesses a remarkable abundance of putative surface proteins, which may permit it to be a primary colonizer of the oral cavity and agent of streptococcal endocarditis and infection in neutropenic patients.

11 June 2010 in BMC Genomics
Verified
Journal Article
Open access
PDF file
MHMichael D Harwich
Michael D Harwich
JAJoão Marcelo Pereira Alves
João Marcelo Pereira Alves
GBGregory Buck
Gregory Buck
JSJerome F Strauss
Jerome F Strauss
JPJennifer L Patterson
Jennifer L Patterson
Kimberly JeffersonKimberly Jefferson
Kimberly Jefferson
Background: Worldwide, bacterial vaginosis (BV) is the most common vaginal disorder. It is associated with risk for preterm birth and HIV infection. The etiology of the condition has been debated for nearly half a century and the lack of knowledge about its cause and progression has stymied efforts to improve therapy and prevention. Gardnerella vaginalis was originally identified as the causative agent, but subsequent findings that it is commonly isolated from seemingly healthy women cast doubt on this claim. Recent studies shedding light on the virulence properties of G. vaginalis, however, have drawn the species back into the spotlight. Results: In this study, we sequenced the genomes of a strain of G. vaginalis from a healthy woman, and one from a woman with bacterial vaginosis. Comparative analysis of the genomes revealed significant divergence and in vitro studies indicated disparities in the virulence potential of the two strains. The commensal isolate exhibited reduced cytotoxicity and yet the cytolysin proteins encoded by the two strains were nearly identical, differing at a single amino acid, and were transcribed at similar levels. The BV-associated strain encoded a different variant of a biofilm associated protein gene and demonstrated greater adherence, aggregation, and biofilm formation. Using filters with different pore sizes, we found that direct contact between the bacteria and epithelial cells is required for cytotoxicity. Conclusions: The results indicated that contact is required for cytotoxicity and suggested that reduced cytotoxicity in the commensal isolate could be due to impaired adherence. This study outlines two distinct genotypic variants of G. vaginalis, one apparently commensal and one pathogenic, and presents evidence for disparate virulence potentials.

17 December 2012 in BMC Genomics
Verified
Journal Article
Open access
PDF file
MHMichael D Harwich
Michael D Harwich
MSMyrna G Serrano
Myrna G Serrano
JFJennifer M Fettweis
Jennifer M Fettweis
JAJoão Marcelo Pereira Alves
João Marcelo Pereira Alves
MRMark A Reimers
Mark A Reimers
Kimberly JeffersonKimberly Jefferson
Kimberly Jefferson
Background: Bacteria of the genus Sneathia are emerging as potential pathogens of the female reproductive tract. Species of Sneathia, which were formerly grouped with Leptotrichia, can be part of the normal microbiota of the genitourinary tracts of men and women, but they are also associated with a variety of clinical conditions including bacterial vaginosis, preeclampsia, preterm labor, spontaneous abortion, post-partum bacteremia and other invasive infections. Sneathia species also exhibit a significant correlation with sexually transmitted diseases and cervical cancer. Because Sneathia species are fastidious and rarely cultured successfully in vitro; and the genomes of members of the genus had until now not been characterized, very little is known about the physiology or the virulence of these organisms. Results: Here, we describe a novel species, Sneathia amnii sp. nov, which closely resembles bacteria previously designated "Leptotrichia amnionii". As part of the Vaginal Human Microbiome Project at VCU, a vaginal isolate of S. amnii sp. nov. was identified, successfully cultured and bacteriologically cloned. The biochemical characteristics and virulence properties of the organism were examined in vitro, and the genome of the organism was sequenced, annotated and analyzed. The analysis revealed a reduced circular genome of ~1.34 Mbp, containing ~1,282 protein-coding genes. Metabolic reconstruction of the bacterium reflected its biochemical phenotype, and several genes potentially associated with pathogenicity were identified. Conclusions: Bacteria with complex growth requirements frequently remain poorly characterized and, as a consequence, their roles in health and disease are unclear. Elucidation of the physiology and identification of genes putatively involved in the metabolism and virulence of S. amnii may lead to a better understanding of the role of this potential pathogen in bacterial vaginosis, preterm birth, and other issues associated with vaginal and reproductive health.